The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interception of molecular relapse in breast cancer: The SURVIVE HERoes study (NCT06643585).
 
Wolfgang Janni
Honoraria - AstraZeneca; Celgene; Chugai Pharma; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Guardant Health; Inivata; Janssen; Lilly; Menarini; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi Aventis GmbH; Seagen
 
Thomas Friedl
No Relationships to Disclose
 
Sophia Huesmann
No Relationships to Disclose
 
Brigitte Rack
Honoraria - AstraZeneca; Novartis
 
Sabine Heublein
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Novartis; Pfizer; Roche
Consulting or Advisory Role - GlaxoSmithKline; Merck Sharp & Dohme; Novartis
 
Henning Schäffler
Honoraria - Gilead Sciences; Novartis
Travel, Accommodations, Expenses - Daiichi Sankyo; Gilead Sciences; Novartis
 
Forca Mehmeti
No Relationships to Disclose
 
Rafael Saup
No Relationships to Disclose
 
Angelina Fink
Honoraria - Clovis Oncology; GlaxoSmithKline; Novartis; Pfizer; Roche
 
Tatjana Braun
No Relationships to Disclose
 
Tanja Fehm
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; MSD Oncology; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Volkmar Mueller
Honoraria - Amgen; AstraZeneca; ClinSol; Daiichi Sankyo; Eisai; Gilead Sciences; GlaxoSmithKline; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Consulting or Advisory Role - Daiichi Sankyo; Eisai; Gilead Sciences; GlaxoSmithKline; Lilly; MSD Oncology; Pfizer; Roche; Seagen; Stemline Therapeutics
Research Funding - AstraZeneca (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Gilead Sciences; Pfizer; Roche
 
Lisa Wiesmueller
No Relationships to Disclose
 
Klaus Pantel
Honoraria - Bristol Myers Squibb Foundation; Guardant Health; Illumina; Menarini Silicon Biosystems; MSD; Roche; Sanofi
Consulting or Advisory Role - Guardant Health; Menarini Silicon Biosystems; OneCell Diagnostics India; Sysmex
Research Funding - IHI GUIDE.MRD Partners (Inst)
Patents, Royalties, Other Intellectual Property - EP 4057007 (Inst); US Patent Application 16/486,913 for PANKA AG (Inst)
 
Andreas Hartkopf
Honoraria - Agendia; Amgen; AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Lilly; Menarini Group; MSD; Novartis; Onkowissen; Pfizer; Pierre Fabre; RIEMSER; Roche; Seagen; Teva; Thieme; Veracyte
Consulting or Advisory Role - Agendia; Amgen; AstraZeneca; Daiichi Sankyo; Exact Sciences; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Lilly; Menarini Group; MSD; Novartis; Onkowissen; Pfizer; Pierre Fabre; RIEMSER; Roche; Teva
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Lilly; Menarini Group; MSD; Novartis; Pfizer; Roche; Seagen; Veracyte
Research Funding - Exact Sciences (Inst); Veracyte (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Lilly; Menarini Group; Novartis; Pfizer; Roche
 
Melanie Hussong
Employment - NeoGenomics Laboratories
 
Amber Chevalier
Employment - NeoGenomics Laboratories
Stock and Other Ownership Interests - NeoGenomics Laboratories
 
Peter Fasching
Honoraria - Agendia; AstraZeneca; Daiichi Sankyo; Eisai; Gilead Sciences; Hexal; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche; SeaGen
Consulting or Advisory Role - Agendia; AstraZeneca; Daiichi Sankyo; Eisai; Gilead Sciences; Guardant Health; Hexal; Lilly; Menarini Group; Merck Sharp & Dohme; Mylan; Novartis; Pfizer; Pierre Fabre; Roche; Seagen; Veracyte
Research Funding - BioNTech (Inst); Cepheid (Inst); Novartis (Inst); Pfizer (Inst); Roche
 
Kerstin Pfister
Honoraria - Gilead Sciences; Novartis; Pfizer
Research Funding - AstraZeneca (Inst)